| Closed |
S2200 |
S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2 |
9/19/2022 |
1/17/2026 |
18% |
|
|
| Closed |
S2007 |
Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases |
12/15/2020 |
4/7/2025 |
64% |
|
|
| Open |
S2212 |
SCARLET |
7/21/2023 |
|
47% |
|
|
| Closed |
S0216 |
SCCHN |
3/1/2003 |
8/19/2004 |
100% |
|
Published
|
| Closed |
S0826 |
SCH 727965 Stage IV Melanoma |
7/1/2009 |
11/1/2010 |
100% |
|
|
| Closed |
SWOG-8500 |
Second-Line Treatment of Advanced Measurable Ovarian Cancer with CHIP |
8/1/1988 |
11/15/1988 |
|
|
Published
|
| Closed |
S0000 |
SELECT (Selenium and Vitamin E Cancer Prevention Trial) |
7/25/2001 |
6/24/2004 |
100% |
|
Published
|
| Closed |
S0000B |
SELECT Eye Endpoints (SEE) |
7/1/2004 |
7/31/2015 |
|
|
Published
|
| Closed |
SWOG-8810 |
Six Courses of 5-Fluorouracil and Cis-Platinum With Correlation of Clinical and Cellular DNA Parameters in Patients with Advanced, Untreated and Unresectable Squamous Cell Carcinoma of the Head and… |
4/1/1988 |
12/15/1992 |
92% |
|
Published
|
| Closed |
SWOG-9130 |
Smoking Cessation for Early Stage Bladder Cancer Patients Using A Combined Brief Physician-Message and Cancer Information Service (CIS) Counseling Approach |
9/1/1992 |
8/17/1995 |
6% |
|
|
| Closed |
S0002 |
Smoking Cessation Stage I & II NSCLC |
1/1/2002 |
1/1/2004 |
2% |
|
|
| Closed |
S0505 |
Soft Tissue Sarcomas |
3/1/2006 |
|
68% |
|
Published
|
| Closed |
S0340 |
Solitary Plasmacytoma |
4/15/2005 |
2/15/2007 |
2% |
|
|
| Closed |
S0011 |
Squamous cell carcinoma |
3/1/2003 |
7/1/2006 |
22% |
|
Published
|
| Closed |
S9712 |
Stage III NSCLC |
2/15/1998 |
6/1/2000 |
100% |
|
Published
|
| Closed |
SWOG-7518 |
Stage IIIA and B Hodgkin's Disease Remission Induction by Radiation Therapy Plus Chemotherapy Combination vs. Chemotherapy Alone |
10/30/1975 |
4/14/1980 |
|
|
Published
|
| Closed |
SWOG-8914 |
Standard Dose Carboplatin/Cyclophosphamide/GM-CSF vs. Intensive Carboplatin/Cyclophosphamide/GM-CSF Induction Therapy - Second-Look Cytoreductive Surgery - Followed by High Dose Day 1 and Day 8 IV… |
9/15/1990 |
6/15/1994 |
40% |
|
|
| Closed |
S9903 |
Stereotactic RT Limited Melanoma Brain Mets |
7/15/1999 |
6/15/2001 |
3% |
|
|
| Closed |
S0331 |
STI-571/Imatinib/Merkel Cell Melanoma |
10/1/2003 |
3/1/2007 |
62% |
|
Published
|
| Open |
S2207 |
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment |
6/30/2023 |
|
15% |
|
|
